Neuroblastoma 3

Common Name(s)

Neuroblastoma 3

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 3" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 3" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroblastoma 3" returned 73 free, full-text research articles on human participants. First 3 results:

Palmitic acid and ergosta-7,22-dien-3-ol contribute to the apoptotic effect and cell cycle arrest of an extract from Marthasterias glacialis L. in neuroblastoma cells.
 

Author(s): David M Pereira, Georgina Correia-da-Silva, Patrícia Valentão, Natércia Teixeira, Paula B Andrade

Journal:

 

We describe the effect of a chemically characterized lipophilic extract obtained from Marthasterias glacialis L. against human breast cancer (MCF-7) and human neuroblastoma (SH-SY5Y) cell lines. Evaluation of DNA synthesis revealed that both cell lines were markedly affected in a ...

Last Updated: 25 Dec 2013

Go To URL
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis.
 

Author(s): Gitta Bleeker, Reineke A Schoot, Huib N Caron, Jan de Kraker, Cees A Hoefnagel, Berthe L van Eck, Godelieve A Tytgat

Journal: Eur. J. Nucl. Med. Mol. Imaging. 2013 Oct;40(11):1711-7.

 

In the treatment of patients with high-risk neuroblastoma, different doses of (131)I-metaiodobenzylguanidine ((131)I-MIBG) are administered at different time points during treatment. Toxicity, mainly haematological (thrombocytopenia), from (131)I-MIBG therapy is known to occur in ...

Last Updated: 2 Oct 2013

Go To URL
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
 

Author(s): Susan G Kreissman, Robert C Seeger, Katherine K Matthay, Wendy B London, Richard Sposto, Stephan A Grupp, Daphne A Haas-Kogan, Michael P Laquaglia, Alice L Yu, Lisa Diller, Allen Buxton, Julie R Park, Susan L Cohn, John M Maris, C Patrick Reynolds, Judith G Villablanca

Journal: Lancet Oncol.. 2013 Sep;14(10):999-1008.

 

Myeloablative chemoradiotherapy and immunomagnetically purged autologous bone marrow transplantation has been shown to improve outcome for patients with high-risk neuroblastoma. Currently, peripheral blood stem cells (PBSC) are infused after myeloablative therapy, but the effect of ...

Last Updated: 2 Sep 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroblastoma 3" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 10 Jun 2014

Go to URL
Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
 

Status: Recruiting

Condition Summary: Neuroblastoma; Bone Marrow, Sympathetic Nervous System

 

Last Updated: 10 Jul 2014

Go to URL
Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma
 

Status: Recruiting

Condition Summary: Neuroblastoma

 

Last Updated: 30 Sep 2014

Go to URL